JAK2 and lung carcinoma: Furthermore, antrocin (187) suppressed tumorigenesis in lung cancer mouse xenograft in vivo and enhanced tumor inhibitory response upon combinatorial treatment of antrocin (187) and JAK2 inhibitor [172].